Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic factor in neuroblastoma.

A E Evans, G J D'Angio, K Propert

    Cancer
    |June 1, 1987
    PubMed
    Summary

    This study identifies key prognostic factors for neuroblastoma, including age, stage, and serum ferritin. These factors can effectively stratify patients into distinct risk groups for improved treatment strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Opting into breast screening over the age of 70 years: seeking evidence to support informed choice.

    Clinical radiology·2022
    Same author

    Wilm's Tumor: An Update.

    Cancer·2018
    Same author

    Molecular regulation of striatal development: a review.

    Anatomy research international·2012
    Same author

    Maternal high-fat diet impacts endothelial function in nonhuman primate offspring.

    International journal of obesity (2005)·2012
    Same author

    The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.

    Breast (Edinburgh, Scotland)·2011
    Same author

    The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B(12) status.

    European journal of clinical nutrition·2010

    Area of Science:

    • Pediatric Oncology
    • Cancer Genomics
    • Biomarker Discovery

    Background:

    • Neuroblastoma is a significant pediatric cancer with variable outcomes.
    • Accurate prognostic factors are crucial for tailoring treatment and improving survival rates.

    Purpose of the Study:

    • To identify independent and most useful prognostic factors for predicting neuroblastoma outcome.
    • To stratify neuroblastoma patients into prognostic groups based on key clinical and biological markers.

    Main Methods:

    • Analysis of known prognostic factors in 124 neuroblastoma patients.
    • Kaplan-Meier survival estimates and recursive partitioning for risk stratification.
    • Evaluation of factors including age, sex, stage, serum neuron-specific enolase (NSE), serum ferritin, and histologic type.

    Main Results:

    • Overall 2-year survival was 60%. Significant survival differences were observed based on pathology, age, NSE, ferritin, VMA:HVA ratio, and stage.
    • Recursive partitioning identified three prognostic groups (good, intermediate, poor) with distinct 2-year survival rates (100%, 62%, 19%) based on ferritin, age, and stage.
    • A combination of age, stage, serum ferritin, and histologic type may define favorable (>80% 2-year survival) and unfavorable (<20% 2-year survival) patient populations.

    Conclusions:

    • Age, stage, serum ferritin, and histologic type are powerful predictors of neuroblastoma outcome.
    • These factors can be combined to stratify patients into distinct risk groups, aiding in treatment decisions.
    • Further research with larger cohorts could refine prognostic models for neuroblastoma.

    Related Experiment Videos